Today: 8 June 2026
Browse Category

TSX:4519 8 July 2025 - 28 November 2025

RANI Stock Today, 28 November 2025: Price Action, Options Expiry and Outlook After the $1 Billion Chugai Deal

RANI Stock Today, 28 November 2025: Price Action, Options Expiry and Outlook After the $1 Billion Chugai Deal

Rani Therapeutics shares traded around $1.59 on 28 November, down from the previous close of $1.62 but still well above pre-October levels. No new press releases or SEC filings were issued today. The stock’s recent surge followed a major Chugai Pharmaceutical collaboration and $60.3 million private placement. Market cap stands near $190–200 million with roughly 97.5 million shares outstanding.
28 November 2025
··
Tokyo Stock Exchange Surges to Record Highs on AI Boom – Inside the Nov 3, 2025 Rally

Japan Stocks Today: Topix Closes at Record 3,359 as Nikkei Ends at 51,063; Sony’s Upgrade Offsets SoftBank Slump, Yen Nears ¥155

Topix closed at a record 3,359.33, up 1.14%, while the Nikkei 225 rose 0.43% to 51,063.31. SoftBank fell after confirming a $5.8 billion sale of its Nvidia stake; Sony jumped on an 8% profit forecast hike. The yen weakened near ¥155 per dollar. About 78% of Prime market stocks advanced.
12 November 2025
········
Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics shares surged over 150% on Oct. 17, 2025, after announcing a collaboration and license deal with Chugai Pharmaceutical worth up to $1.085 billion. The company also raised $60.3 million in PIPE financing, stating it now has funding into 2028. Trading volume spiked to 70 million shares, up from a 300,000 average. Analyst opinions remain split on the stock’s outlook.
18 October 2025
···
Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Rani Therapeutics shares surged nearly 190% to $1.37 on Oct. 17, 2025, after announcing a pharma partnership with Chugai Pharmaceutical worth up to $1.085 billion. The deal includes $10 million upfront, development and sales milestones, and potential royalties. Rani also raised $60.3 million in a private placement, extending its cash runway into 2028. Trading volume spiked to several times the daily average.
17 October 2025
···
The State of AI: Agentic Revolution, Healthcare Breakthroughs & Global Governance / Updated: 2025, July 8th, 12:00 CET

The State of AI: Agentic Revolution, Healthcare Breakthroughs & Global Governance / Updated: 2025, July 8th, 12:00 CET

More than 777 FDA-cleared AI devices are in clinical use for medical imaging in the U.S., cutting scan times and flagging urgent cases. Microsoft's MAI-DxO system reached 85.5% diagnostic accuracy, far above doctors at 20%. The U.S. Senate rejected a 10-year moratorium on state AI regulation. Meta recruited Apple’s Ruoming Pang for its AI push, while Wimbledon 2025 adopted AI-driven line calling amid player criticism.
8 July 2025
······

Stock Market Today

  • Alphabet Stock Seen Surging to $600 by 2028 on AI and Cloud Growth
    June 8, 2026, 10:36 AM EDT. Alphabet Inc (GOOGL) stock is projected to reach $453.04 within 12 months, a 21.59% increase from its current $372.58, according to 24/7 Wall St. A bull case anticipates shares hitting $604.63 by June 2, 2028, backed by strong AI monetization, an $80 billion equity raise including a $10 billion Berkshire Hathaway investment, and a $460 billion Google Cloud backlog. Despite a 2.78% pullback from May peaks, analysts maintain a 90% confidence level with a Buy rating. Risks include elevated 2026 capital expenditure guidance of up to $185 billion and regulatory scrutiny in the EU and US. Nevertheless, operating margins expanded to 36.1% in Q1, underpinning optimism for sustainable growth.

Latest articles

Mortgage Rates Fall but Buyers Still Face Pressure

Mortgage Rates Fall but Buyers Still Face Pressure

8 June 2026
U.S. mortgage rates dipped to 6.48% from 6.53%, offering slight relief as the housing market faces falling listing prices—down 2.4% year-over-year to $429,500—but persistent high borrowing costs and strong jobs data threaten to push rates higher, risking further pressure on home sales and affordability.
QQQ Slides 4.8% But Options Market Sends Mixed Signals

QQQ Slides 4.8% But Options Market Sends Mixed Signals

8 June 2026
QQQ jumped 1.6% to $716.47 Monday after a 4.8% drop, as options data showed traders cautious but not panicked; the rebound follows a tech selloff sparked by Fed rate fears and AI spending doubts, while upcoming Nasdaq-100 rebalancing and new ETF competition add uncertainty for investors.
SOXL’s 433% Rally in AI Chip Sector Meets Sharp Pullback

SOXL’s 433% Rally in AI Chip Sector Meets Sharp Pullback

8 June 2026
SOXL surged nearly 15% to $209.62 Monday after last week’s 30.5% plunge, as chip stocks rebounded from a $1.3 trillion rout; leveraged ETF swings highlight the risks of daily resets, with Direxion and regulators warning these funds are trading tools, not long-term bets, especially as investors eye upcoming inflation data and Fed meetings.
Corning Wins Amazon AI Fiber Deal; GLW Faces Next Hurdle

Corning Wins Amazon AI Fiber Deal; GLW Faces Next Hurdle

8 June 2026
Amazon’s new multibillion-dollar supply deal makes Corning a key fiber provider for U.S. data centers, but with shares up 305% in 12 months and investors already pricing in big AI wins, the stock was little changed at $177.58 premarket as risks of factory delays and high expectations loom.
BlackBerry Shares Stall After QNX Push

BlackBerry Stock Moves in Pre-Market Ahead of June Test

8 June 2026
BlackBerry’s U.S. shares rose 2.34% in premarket trading to $9.63 after Friday’s 8.99% drop, but with analyst targets averaging just $4.98, investors are betting on QNX growth and secure-communications wins ahead of June 25 earnings; any disappointment could hit the stock hard.
Go toTop